Superseded · version 2: Elamipretide^↗

Related names recorded in this version: SS-31, MTP-131^↗

A mitochondria-targeting peptide candidate. This profile cites a recruiting ClinicalTrials.gov study record.^↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.

Update · July 27, 2026

We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. ¹

What this version reported

ClinicalTrials.gov lists the 4TAZPower study as recruiting, updated July 13, 2026.^↗

Organizations named in cited records:

Trial records: NCT07531251